Epidemiology of rheumatoid arthritis: Rheumatoid arthritis and mortality

被引：127

作者：

Myasoedova E. ^{[1
]}

Davis III J.M. ^{[2
]}

Crowson C.S. ^{[2
]}

Gabriel S.E. ^{[1
]}

机构：

[1] Department of Health Sciences Research, Mayo Clinic, Rochester, MN

[2] Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN 55905

来源：

Current Rheumatology Reports | 2010年 / 12卷 / 5期

关键词：

Accelerated aging; CV disease; Inflammation; Mortality; Rheumatoid arthritis;

D O I：

10.1007/s11926-010-0117-y

中图分类号：

学科分类号：

摘要：

Increased mortality in rheumatoid arthritis (RA) is widely recognized but not fully explained. Despite substantial improvements in management and growing knowledge of the determinants of increased mortality, evidence for reduction in mortality in RA has lagged behind. Indeed, most studies report no apparent reduction in mortality in RA. However, emerging evidence from some recent RA inception cohorts suggests no increased mortality, including cardiovascular mortality, but this awaits further confirmation. Although it is possible that recent advances in RA treatment may manifest in improvement of survival in the near future, other factors, including undertreated or unrecognized low-grade inflammation, comorbidities, and immunogenetic factors, may contribute to the excess mortality in RA and impede its improvement. In this review, we summarize the current knowledge of the rates and determinants of mortality in RA, identify and discuss potential explanations for excessmortality, and outline promising research avenues for targeting mortality in RA. © Springer Science+Business Media, LLC 2010.

引用

页码：379 / 385

页数：6

共 50 条

[1]

Gonzalez A., Maradit Kremers H., Crowson C.S., Et al., The widening mortality gap between rheumatoid arthritis patients and the general population, Arthritis Rheum, 56, pp. 3583-3587, (2007)

[2]

Gonzalez A., Icen M., Kremers H.M., Et al., Mortality trends in rheumatoid arthritis: The role of rheumatoid factor, J Rheumatol, 35, pp. 1009-1014, (2008)

[3]

Ziade N., Jougla E., Coste J., Population-level influence of rheumatoid arthritis on mortality and recent trends: A multiple cause-of-death analysis in France, 1970-2002, J Rheumatol, 35, pp. 1950-1957, (2008)

[4]

Bergstrom U., Jacobsson L.T., Turesson C., Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden, Rheumatology (Oxford), 48, pp. 1600-1605, (2009)

[5]

Radovits B.J., Fransen J., Al Shamma S., Et al., Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis, Arthritis Care Res (Hoboken), 62, pp. 362-370, (2010)

[6]

Puolakka K., Kautiainen H., Pohjolainen T., Virta L., No increased mortality in incident cases of rheumatoid arthritis during the new millennium, Ann Rheum Dis, (2010)

[7]

Avina-Zubieta J.A., Choi H.K., Sadatsafavi M., Et al., Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies, Arthritis Rheum, 59, pp. 1690-1697, (2008)

[8]

Meune C., Touze E., Trinquart L., Allanore Y., Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: A systematic review and meta-analysis of cohort studies, Rheumatology (Oxford), 48, pp. 1309-1313, (2009)

[9]

Poole C.D., Conway P., Currie C.J., An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice, Rheumatology (Oxford), 48, pp. 78-82, (2009)

[10]

Troelsen L.N., Garred P., Jacobsen S., Mortality and predictors of mortality in rheumatoid arthritis-A role for mannose-binding lectin?, J Rheumatol, 37, pp. 536-543, (2010)

← 1 2 3 4 5 →